Abstract

O-acetylserine sulfhydrylase (OASS) is the pyridoxal 5′-phosphate dependent enzyme that catalyses the formation of L-cysteine in bacteria and plants. Its inactivation is pursued as a strategy for the identification of novel antibiotics that, targeting dispensable proteins, holds a great promise for circumventing resistance development. In the present study, we have investigated the reactivity of Salmonella enterica serovar Typhimurium OASS-A and OASS-B isozymes with fluoroalanine derivatives. Monofluoroalanine reacts with OASS-A and OASS-B forming either a stable or a metastable α-aminoacrylate Schiff’s base, respectively, as proved by spectral changes. This finding indicates that monofluoroalanine is a substrate analogue, as previously found for other beta-halogenalanine derivatives. Trifluoroalanine caused different and time-dependent absorbance and fluorescence spectral changes for the two isozymes and is associated with irreversible inhibition. The time course of enzyme inactivation was found to be characterised by a biphasic behaviour. Partially distinct inactivation mechanisms for OASS-A and OASS-B are proposed.

Highlights

  • Sulfur is a fundamental component of many biomolecules, from amino acids to cofactors and compounds that control the redox homoeostasis

  • On the basis of the spectral and kinetic data obtained by monitoring the reactivity of triF-Ala with O-acetylserine sulfhydrylase (OASS) and taking into account reaction schemes previously proposed in the reaction of triF-Ala with other pyridoxal 50-phosphate (PLP)-dependent enzymes[20,22,24,25,29,30,36], we propose an inactivation mechanism for OASS-A that is similar to the mechanism proposed for alanine racemase[30] (Scheme 2, path B)

  • The search for reversible and irreversible inhibitors of OASS-A and OASS-B is dictated by the relevance of these enzymes in the biosynthesis of cysteine in bacteria and by their absence in mammals

Read more

Summary

Introduction

Sulfur is a fundamental component of many biomolecules, from amino acids to cofactors and compounds that control the redox homoeostasis. OASS is present in bacteria as two isoforms, OASS-A and OASSB, named CysK and CysM after the coding genes. Because SAT binding to OASS-A involves anchoring of its C-terminus in OASS-A active site, complex formation leads to the competitive inhibition of OASS-A activity. Both isoforms are present in bacteria but not in humans. Bacteria knocked-out for cysK and cysM exhibit a phenotype with reduced virulence, compromised fitness, and decreased antibiotic resistance[9,10]. For these reasons, OASS has been the target of multiple medicinal chemistry efforts to identify reversible inhibitors potentially useful as antibiotics or enhancers of antibiotic activity[11,12].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call